Courtney Shelton, MD
Internal Medicine · Atlanta, GANPI 1609874023
Payments from drug & device makers
Across 208 payments — averaging $5705.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$932K
- Eli Lilly$122K
- Currax Pharmaceuticals LLC$51K
- AstraZeneca$46K
- Incyte Corporation$21K
- Novo Nordisk AS$6K
- plus $10K from 18 others
Across 6 payments — averaging $2889.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$17K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 3 | $931,514 |
| Eli Lilly | 8 | $121,807 |
| Currax Pharmaceuticals LLC | 14 | $50,625 |
| AstraZeneca | 22 | $45,849 |
| Incyte Corporation | 63 | $20,788 |
| Novo Nordisk AS | 2 | $6,180 |
| Boehringer Ingelheim | 3 | $3,045 |
| Mallinckrodt Enterprises LLC | 2 | $2,481 |
| Vanda Pharmaceuticals Inc. | 19 | $1,824 |
| Mallinckrodt Hospital Products Inc. | 1 | $850 |
| Bayer | 11 | $327 |
| Abbott | 8 | $323 |
| Lilly USA, LLC | 17 | $292 |
| Novo Nordisk | 11 | $231 |
| GSK | 8 | $203 |
| Exact Sciences | 4 | $84 |
| Kerecis Limited | 1 | $72 |
| Galt Pharmaceuticals, LLC | 1 | $72 |
| Johnson & Johnson(2 entities) | 3 | $66 |
| Dexcom, Inc. | 2 | $40 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Novartis | 1 | $21 |
| Avanos Medical | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$1,186,759 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Atlanta
- Kimball JohnsonAtlanta$51.1M
- Robert Springer IiiAtlanta$5.3M
- Paulina Rebolledo EsteinouAtlanta$2.1M
- Melanie ThompsonAtlanta$1.1M
- Tracey HenryAtlanta$305K
- David WatsonAtlanta$286K
- Priscilla Igho-PemuAtlanta$269K
- Robert HerreraAtlanta$261K
- Syed RahmanAtlanta$211K
- Scott ParryAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.